High-dose intratympanic gentamicin instillations for treatment of Meniere's disease: Long-term results

Acta Oto-Laryngologica

Volumn 129, Issue 12, 2009, Pages 1420-1424

  Hsieh, Li Chun ^a   Lin, Hung Ching ^a,c   Tsai, Hsun Tien ^a,b   Ko, Yi Ching ^b   Shu, Min Tsan ^a   Lin, Li Hui ^a  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL TAIPEI UNIVERSITY OF NURSING AND HEALTH SCIENCES   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Gentamicin; Intratympanic therapy; Meniere's disease

Indexed keywords

GENTAMICIN;

ADULT; AGED; ARTICLE; AUDITORY THRESHOLD; CLINICAL ARTICLE; DISEASE CONTROL; DRUG INSTILLATION; DRUG MEGADOSE; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HUMAN; MALE; MENIERE DISEASE; PERCEPTION DEAFNESS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PURE TONE AUDIOMETRY; TREATMENT DURATION; TREATMENT FAILURE; VERTIGO;

ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; GENTAMICINS; HEARING LOSS; HUMANS; MALE; MENIERE DISEASE; MIDDLE AGED; PROTEIN SYNTHESIS INHIBITORS; VERTIGO;

EID: 70450187041     PISSN: 00016489     EISSN: 16512553     Source Type: Journal    
DOI: 10.3109/00016480902856612     Document Type: Article

References (16)

1. Committee on Hearing and Equilibrium Guidelines for the diagnosis and evaluation of therapy in Meniere's disease. American Academy of Otolaryngology-Head and Neck Surgery Foundation, Inc. Otolaryngol Head Neck Surg 1995;113:181-185.
2. Fowler EP. Streptomycin treatment of vertigo. Trans Am Acad Ophthalmol Otolaryngol 1948;/52:/239-301.
3. Nedzelski JM, Schessel DA, Bryce GE, Pfleiderer AG. Chemical labyrinthectomy: local application of gentamicin for the treatment of unilateral Meniere's disease. Am J Otol 1992;/13:/18-22.
4. Driscoll CLW, Kasperbauer JL, Facer GW, Harner SG, Beatty CW. Low-dose intratympanic gentamicin and the treatment of Meniere's disease: preliminary results. Laryngoscope 1997;/107:/83-9.
5. Blakley BW. Update on intratympanic gentamicin for Meniere's disease. Laryngoscope 2000;/110:/236-9.
6. Bodmer D, Morong S, Stewart C, Alexander A, Chen JM, Nedzeski JM. Long term vertigo control in patients after intatympanic gentamicin instillation for Meniere's disease. Otol Neurotol 2007;/28:/1140-4.
7. Lange G, Maurer J, Mann W. Long-term results after interval therapy with intratympanic gentamicin for Meniere's disease. Laryngoscope 2004;/114:/102-5.
8. Perez N, Martin E, Garcia-Tapia R. Intratympanic gentamicin for intractable Meniere's disease. Laryngoscope 2003;/ 113:/456-64.
9. Harner SG, Drsicoll CL, Facer GW, Beatty CW, McDonald TJ. Long term follow-up of intratympanic gentamicin for Meniere's syndrome. Otol Neurotol 2001;/22:/210-4.
10. Martin E, Perez N. Hearing loss after intratympanic gentamicin therapy for unilateral Meniere's disease. Otol Neurotol 2003;/24:/800-6.
11. Wu IC, Minor LB. Long-term hearing outcome in patients receiving intratympanic gentamicin for Meniere's disease. Laryngoscope 2003;/113:/815-20.
12. Berryhill WE, Graham MD. Chemical and physical labyrinthectomy for Meniere's disease. Otolaryngol Clin North Am 2002;/35:/675-82.
13. Kerem RC, Kisilevsky V, Elinarson TR, Kozer E, Koren G, Rutka JA. Intratympanic gentamicin for Meniere's disease: a meta-analysis. Laryngoscope 2004;/114:/2085-91.
14. Colletti V, Carner M, Colletti L. Auditory results after vestibular nerve section and intratympanic gentamicin for Meniere's disease. Otol Neurotol 2007;/28:/145-51.
15. Chia SH, Gamst AC, Anderson JP, Harris JP. Intratympanic gentamicin therapy for Meniere's disease: a meta-analysis. Otol Neurotol 2004;/25:/544-52.
16. Guan MX, Fischel-Ghodsian N, Attardi G. Nuclear background determines biochemical phenotype in the deafnessassociated mitochondria 12S rRNA mutation. Hum Mol Genet 2001;/10:/573-80.